Efficacy and Safety of Peginterferon Beta-1a (CinnaGen) in Participants With Relapsing Remitting Multiple Sclerosis

NCT05242133 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis (RRMS)

Interventions

DRUG: Pegylated interferon beta-1a
DRUG: Interferon Beta-1A Prefilled Syringe

Sponsor

Cinnagen